PL2776455T3 - Rodopsyny kanałowe do kontroli optycznej komórek - Google Patents
Rodopsyny kanałowe do kontroli optycznej komórekInfo
- Publication number
- PL2776455T3 PL2776455T3 PL12808926T PL12808926T PL2776455T3 PL 2776455 T3 PL2776455 T3 PL 2776455T3 PL 12808926 T PL12808926 T PL 12808926T PL 12808926 T PL12808926 T PL 12808926T PL 2776455 T3 PL2776455 T3 PL 2776455T3
- Authority
- PL
- Poland
- Prior art keywords
- channelrhodopsins
- cells
- optical control
- optical
- control
- Prior art date
Links
- 108010035848 Channelrhodopsins Proteins 0.000 title 1
- 230000003287 optical effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48728—Investigating individual cells, e.g. by patch clamp, voltage clamp
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559076P | 2011-11-12 | 2011-11-12 | |
| EP12808926.5A EP2776455B1 (en) | 2011-11-12 | 2012-11-12 | Channelrhodopsins for optical control of cells |
| PCT/US2012/064665 WO2013071231A1 (en) | 2011-11-12 | 2012-11-12 | Channelrhodopsins for optical control of cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2776455T3 true PL2776455T3 (pl) | 2018-07-31 |
Family
ID=47470101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12808926T PL2776455T3 (pl) | 2011-11-12 | 2012-11-12 | Rodopsyny kanałowe do kontroli optycznej komórek |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US10472398B2 (pl) |
| EP (2) | EP2776455B1 (pl) |
| KR (2) | KR102194185B1 (pl) |
| DK (2) | DK3214094T3 (pl) |
| ES (2) | ES2801679T3 (pl) |
| HK (2) | HK1202128A1 (pl) |
| PL (1) | PL2776455T3 (pl) |
| WO (1) | WO2013071231A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130309278A1 (en) * | 2005-08-05 | 2013-11-21 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| US9962558B2 (en) * | 2005-08-05 | 2018-05-08 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| US10022457B2 (en) * | 2005-08-05 | 2018-07-17 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| EP2776455B1 (en) | 2011-11-12 | 2018-01-10 | Massachusetts Institute of Technology | Channelrhodopsins for optical control of cells |
| JP2017506889A (ja) * | 2014-02-07 | 2017-03-16 | マサチューセッツ インスティテュート オブ テクノロジー | 青色光活性化イオンチャネル分子およびその使用 |
| WO2015161308A1 (en) | 2014-04-18 | 2015-10-22 | Massachusetts Institute Of Technology | Mutant channelrhodopsins with altered ion selectivity |
| US10882892B2 (en) | 2014-08-05 | 2021-01-05 | Massachusetts Institute Of Technology | Channelrhodopsin variants and uses thereof |
| WO2017187272A1 (en) | 2016-04-29 | 2017-11-02 | Gensight Biologics Sa | Optogenetic visual restoration using chrimson |
| EP3464342A1 (en) | 2016-06-03 | 2019-04-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mutant light-inducible ion channel of chrimson |
| US20190218256A1 (en) | 2016-06-03 | 2019-07-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Mutant light-inducible ion channel of channelrhodopsin |
| AU2017285331C1 (en) | 2016-06-17 | 2023-04-06 | Centre National De La Recherche Scientifique | Device for illuminating an object with a controlled light intensity and associated method |
| WO2018017831A1 (en) * | 2016-07-21 | 2018-01-25 | Massachusetts Institute Of Technology | Dummy-fluorescent protein fusions and methods of use |
| IL310142A (en) | 2016-08-29 | 2024-03-01 | Univ Wayne State | Identification of mutant canlopsin variants with enhanced photosensitivity and methods for their use |
| JP6779546B2 (ja) * | 2016-11-06 | 2020-11-04 | ナノスコープ テクノロジーズ エルエルシーＮａｎｏｓｃｏｐｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ | 視力回復のための多特性オプシンによる光遺伝学的調節及びその別の用途 |
| EP3422065A1 (en) | 2017-06-28 | 2019-01-02 | Gensight Biologics | Objective, camera and system adapted for optogenetics comprising such objective |
| ES2954941T3 (es) | 2018-01-11 | 2023-11-27 | Gensight Biologics | Procedimiento y dispositivo para el procesamiento de señales asíncronas generadas por un sensor de luz basado en eventos |
| TWI653037B (zh) | 2018-01-11 | 2019-03-11 | 友睦科技股份有限公司 | 可控溫的遠紅外線照射設備 |
| WO2020061079A1 (en) * | 2018-09-18 | 2020-03-26 | California Institute Of Technology | Engineered light-sensitive proteins |
| EP3693061A1 (en) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Method for controlling an optogenetic device using filtering and associated devices |
| EP3693060A1 (en) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Method for controlling an optogenetic device using a command law for the radiant power of a light source and associated devices |
| EP3733139A1 (en) | 2019-05-02 | 2020-11-04 | Gensight Biologics | Viewing apparatus and method for projecting a light signal |
| US11454402B1 (en) | 2021-12-01 | 2022-09-27 | Mcevoy William B | Tabletop cooking assembly |
| EP4223768A1 (en) | 2022-02-04 | 2023-08-09 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Novel mutant bacteriorhodopsin-like-channelrhodopsin ion channel |
| WO2024015705A1 (en) * | 2022-07-09 | 2024-01-18 | Bionic Sight, Llc | An optogenetic gene therapy for treating blindness |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0335326B1 (en) | 1988-03-28 | 1994-06-15 | Canon Kabushiki Kaisha | Ion permeable membrane and ion transport method by utilizing said membrane |
| WO1998019217A1 (de) | 1996-10-25 | 1998-05-07 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur vorbereitung der erzeugung strukturierter metallschichten mit hilfe von proteinen |
| EP1307474B1 (de) | 2000-07-27 | 2010-03-03 | MIB - Munich Innovative Biomaterials GmbH | Protonen-translozierende retinalproteine mit konstantem all-trans-retinal-gehalt und verlangsamten photozyklus |
| DE10216005A1 (de) | 2002-04-11 | 2003-10-30 | Max Planck Gesellschaft | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
| WO2007024391A2 (en) | 2005-07-22 | 2007-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Light-activated cation channel and uses thereof |
| EP2019588A4 (en) * | 2006-05-04 | 2010-11-24 | Univ Wayne State | RECOVERY OF VISUAL REACTIONS BY IN VIVO ADMINISTRATION OF RHODOPSIN NUCLEIC ACIDS |
| WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| US20110165681A1 (en) | 2009-02-26 | 2011-07-07 | Massachusetts Institute Of Technology | Light-Activated Proton Pumps and Applications Thereof |
| US9138596B2 (en) * | 2007-08-22 | 2015-09-22 | Cardiac Pacemakers, Inc. | Optical depolarization of cardiac tissue |
| JP5544659B2 (ja) * | 2008-03-24 | 2014-07-09 | 国立大学法人東北大学 | 改変された光受容体チャネル型ロドプシンタンパク質 |
| PT2271369E (pt) * | 2008-04-18 | 2014-07-10 | Novartis Forschungsstiftung | Novas ferramentas terapêuticas e métodos para tratar a cegueira |
| DE102008020152B4 (de) * | 2008-04-22 | 2012-04-05 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| KR20110005280A (ko) * | 2008-04-23 | 2011-01-17 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 표적 세포의 광학적 자극을 위한 시스템, 방법 및 조성물 |
| US20100087006A1 (en) | 2008-09-18 | 2010-04-08 | TransAlgae Ltd | Use of fluorescent protein in cyanobacteria and algae for improving photosynthesis and preventing cell damage |
| NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
| ES2716819T3 (es) | 2010-11-05 | 2019-06-17 | Univ Leland Stanford Junior | Opsinas quiméricas activadas por luz y métodos de uso de las mismas |
| CA2816990A1 (en) * | 2010-11-05 | 2012-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized step function opsin proteins and methods of using the same |
| US20120214188A1 (en) | 2010-11-12 | 2012-08-23 | Nathan Klapoetke | Light-activated ion channel molecules and uses thereof |
| US8957028B2 (en) | 2010-11-13 | 2015-02-17 | Massachusetts Institute Of Technology | Red-shifted opsin molecules and uses thereof |
| EP2776455B1 (en) | 2011-11-12 | 2018-01-10 | Massachusetts Institute of Technology | Channelrhodopsins for optical control of cells |
-
2012
- 2012-11-12 EP EP12808926.5A patent/EP2776455B1/en active Active
- 2012-11-12 PL PL12808926T patent/PL2776455T3/pl unknown
- 2012-11-12 WO PCT/US2012/064665 patent/WO2013071231A1/en active Application Filing
- 2012-11-12 KR KR1020207005571A patent/KR102194185B1/ko active IP Right Grant
- 2012-11-12 EP EP17165633.3A patent/EP3214094B1/en active Active
- 2012-11-12 US US14/357,635 patent/US10472398B2/en active Active
- 2012-11-12 ES ES17165633T patent/ES2801679T3/es active Active
- 2012-11-12 KR KR1020147015784A patent/KR102084803B1/ko active IP Right Grant
- 2012-11-12 ES ES12808926.5T patent/ES2660114T3/es active Active
- 2012-11-12 DK DK17165633.3T patent/DK3214094T3/da active
- 2012-11-12 DK DK12808926.5T patent/DK2776455T3/en active
-
2015
- 2015-03-16 HK HK15102671.5A patent/HK1202128A1/xx unknown
-
2016
- 2016-11-23 US US15/359,875 patent/US10472399B2/en active Active
-
2018
- 2018-03-05 HK HK18103122.5A patent/HK1243717A1/zh unknown
-
2019
- 2019-08-02 US US16/530,047 patent/US10717769B2/en active Active
- 2019-09-13 US US16/570,429 patent/US10711044B2/en active Active
-
2020
- 2020-05-28 US US16/885,457 patent/US11274128B2/en active Active
-
2022
- 2022-02-10 US US17/668,766 patent/US20220169684A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220169684A1 (en) | 2022-06-02 |
| KR102194185B1 (ko) | 2020-12-22 |
| US10711044B2 (en) | 2020-07-14 |
| US10472398B2 (en) | 2019-11-12 |
| US20200291074A1 (en) | 2020-09-17 |
| DK3214094T3 (da) | 2020-07-13 |
| WO2013071231A1 (en) | 2013-05-16 |
| KR102084803B1 (ko) | 2020-03-05 |
| US20200031883A1 (en) | 2020-01-30 |
| EP3214094B1 (en) | 2020-04-01 |
| EP2776455B1 (en) | 2018-01-10 |
| DK2776455T3 (en) | 2018-02-26 |
| US20170088590A1 (en) | 2017-03-30 |
| EP3214094A1 (en) | 2017-09-06 |
| ES2801679T3 (es) | 2021-01-12 |
| HK1243717A1 (zh) | 2018-07-20 |
| KR20140091743A (ko) | 2014-07-22 |
| ES2660114T3 (es) | 2018-03-20 |
| US10717769B2 (en) | 2020-07-21 |
| US20140324134A1 (en) | 2014-10-30 |
| US10472399B2 (en) | 2019-11-12 |
| EP2776455A1 (en) | 2014-09-17 |
| US11274128B2 (en) | 2022-03-15 |
| HK1202128A1 (en) | 2015-09-18 |
| US20190352347A1 (en) | 2019-11-21 |
| KR20200024336A (ko) | 2020-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243717A1 (zh) | 用於細胞的光控的光敏感通道 | |
| EP2771455A4 (en) | CELL LINE FOR GENERATING AN ADENO-ASSOCIATED VIRUS | |
| ZA201400678B (en) | Alpha-amylase variants | |
| EP2682469A4 (en) | OPTICALLY CONTROLLED GENE EXPRESSION SYSTEM | |
| EP2700869A4 (en) | OPTICAL UNIT | |
| GB201200835D0 (en) | Lenses | |
| SG10201601434RA (en) | Cell Culture System | |
| GB201118579D0 (en) | Control of ion populations | |
| EP3008748A4 (en) | Ion optical elements | |
| EP2725401A4 (en) | OPTICAL LENS SYSTEM | |
| HK1209560A1 (en) | Mechanism for discovery of small cells | |
| GB201110042D0 (en) | Growth of cells | |
| EP2719942A4 (en) | OPTICAL UNIT | |
| EP2788811A4 (en) | CONTROL OF LIGHT WAVING FRONTS | |
| EP2709204A4 (en) | OXYGEN CELL | |
| SG11201403280PA (en) | Bioreactor | |
| EP2725342A4 (en) | CELL FOR OPTICAL ANALYSIS | |
| GB201410312D0 (en) | Photobioreactor | |
| EP2677525A4 (en) | Reactor | |
| HK1202578A1 (en) | Expression cassette | |
| EP2788805A4 (en) | OPTICAL CONNECTIONS | |
| GB201217406D0 (en) | Optical cell | |
| HUE058968T2 (hu) | Sejtkultúra tenyésztésére szolgáló eszköz | |
| EP2768941A4 (en) | photobioreactor | |
| EP2681005A4 (en) | LASER DRAWING CONTROL |